| CERS Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the CERS shares outstanding history going back to 2/19/2010:
Also see: CERS Market Cap History CERS YTD Return |
CERS Shares Outstanding History — Cerus Share Count Over Time
As of 4/16/2026 Cerus has 200.37 million CERS shares outstanding. Investors often track the CERS shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows CERS share count trends over time, with 65 historical shares outstanding datapoints presented, dating back to 2/19/2010.
| CERS Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CERS Historical Shares Outstanding: +10.69% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CERS Stock Price Chart |
| About Cerus Corp. |
| Cerus Corporation is a biomedical products company. Co. is focused on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The INTERCEPT Blood System, which is based on its proprietary technology for controlling biological replication, is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. Its INTERCEPT Blood System is intended for use with blood components and certain of their derivatives: platelets, plasma, red blood cells and to produce INTERCEPT Fibrinogen Complex (IFC), and pathogen reduced plasma, cryoprecipitate reduced. We show 65 historical shares outstanding datapoints in our coverage of CERS's shares outstanding history. Understanding the changing numbers of CERS shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like CERS versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching CERS by allowing them to research CERS shares outstanding history as well as any other stock in our coverage universe. |
| CERS Current Stock Quote |
Quotes delayed 20 minutes  Free CERS Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| CERS Share Performance |
| Shares Outstanding Peers |
| Cerus (CERS) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
CFMS Shares Outstanding History CFRX Shares Outstanding History CGEM Shares Outstanding History CGEN Shares Outstanding History CGIX Shares Outstanding History CGNT Shares Outstanding History CGON Shares Outstanding History CGTX Shares Outstanding History CHE Shares Outstanding History CHFS Shares Outstanding History More Healthcare companies » |
CERS Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
